Cinemark Holdings (CNK) reported $540.7 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 6.7%. EPS of -$0.32 for the same period compares to $0.19 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $519.59 million, representing a surprise of +4.06%. The company has not delivered EPS surprise, with the consensus EPS estimate being -$0.32.
While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.
Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.
Here is how Cinemark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- Average ticket price - U.S. Operating Segment: $10.08 versus $9.87 estimated by three analysts on average.
- Average ticket price - International Operating Segment: $3.53 versus $3.62 estimated by three analysts on average.
- Concession revenues per patron - U.S. Operating Segment: $7.98 compared to the $7.78 average estimate based on three analysts.
- Concession revenues per patron - International Operating Segment: $2.88 compared to the $2.87 average estimate based on three analysts.
- Revenue- U.S. Operating Segment- Admissions: $207.60 million compared to the $205 million average estimate based on three analysts. The reported number represents a change of -10.4% year over year.
- Revenue- International Operating Segment- Admissions: $56.50 million compared to the $51.54 million average estimate based on three analysts. The reported number represents a change of -2.6% year over year.
- Revenue- U.S. Operating Segment- Concession: $164.40 million versus $161.53 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -8% change.
- Revenue- International Operating Segment- Concession: $46 million compared to the $40.83 million average estimate based on three analysts. The reported number represents a change of +0.9% year over year.
- Revenue- U.S. Operating Segment- Other: $45.10 million versus $41.54 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -3.2% change.
- Revenue- Admissions: $264.10 million compared to the $259.33 million average estimate based on five analysts. The reported number represents a change of -8.9% year over year.
- Revenue- Other: $66.20 million versus $61.03 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +1.5% change.
- Revenue- Concession: $210.40 million versus $205.44 million estimated by five analysts on average. Compared to the year-ago quarter, this number represents a -6.2% change.
View all Key Company Metrics for Cinemark here>>>
Shares of Cinemark have returned +19.6% over the past month versus the Zacks S&P 500 composite's -0.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Cinemark Holdings Inc (CNK) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.